SCHEMBL31322011

SCHEMBL31322011

CN(C)[C@@H]1CCN(c2ccc(C=O)c(Cl)c2)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2B P41595 2/20 0.44
▸ HTR6 P50406 2/20 0.44
▸ MCHR1 Q99705 6/20 0.43
▸ NOTUM Q6P988 3/20 0.42
▸ PDGFRB P09619 1/20 0.42
▸ FGFR1 P11362 1/20 0.42
▸ KDR P35968 1/20 0.42
▸ INSR P06213 1/20 0.41
▸ IGF1R P08069 1/20 0.41
▸ ALK Q9UM73 1/20 0.41
▸ NTSR1 P30989 1/20 0.40
▸ PIM1 P11309 1/20 0.39
▸ PIM3 Q86V86 1/20 0.39
▸ PIM2 Q9P1W9 1/20 0.39
▸ MAP4K4 O95819 1/20 0.39
▸ HSD11B1 P28845 1/20 0.39
▸ ZAP70 P43403 1/20 0.39
▸ FPR1 P21462 1/20 0.38
▸ FPR2 P25090 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20236407 0.80 NPY5R (0.50) MCHR1NOTUMHSD11B1FPR1FPR2
SCHEMBL20236406 0.80 NPY5R (0.50) MCHR1NOTUMHSD11B1FPR1FPR2
SCHEMBL1750257 0.80 MCHR1 (0.42) HTR2BHTR6MCHR1NOTUMPDGFRB
SCHEMBL4118087 0.77 ALDH1A1 (0.50) MCHR1PIM1PIM3PIM2
SCHEMBL4117384 0.77 ALDH1A1 (0.50) MCHR1PIM1PIM3PIM2
SCHEMBL2424720 0.77 HRH4 (0.45) MCHR1NOTUMPIM1PIM3PIM2
SCHEMBL2424717 0.77 HRH4 (0.45) MCHR1NOTUMPIM1PIM3PIM2
SCHEMBL24680813 0.77 NOTUM (0.47) MCHR1NOTUMHSD11B1FPR1FPR2
SCHEMBL29914613 0.77 NOTUM (0.47) MCHR1NOTUMHSD11B1FPR1FPR2
SCHEMBL2421341 0.76 NOTUM (0.45) HTR2BHTR6MCHR1NOTUMPIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240366615-A1 POLQ INHIBITORS ASTRAZENECA UK LIMITED (GB) 2024-11-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240366615-A1 POLQ INHIBITORS POLQ, POLG, POLB HTR2B 4539/4885HTR6 4806/4885MCHR1 4483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback